doi: 10.1001/jama.2010.1695.
Accelerated approval and possible withdrawal of midodrine
Affiliations
- PMID: 21081731
- DOI: 10.1001/jama.2010.1695
Item in Clipboard
Accelerated approval and possible withdrawal of midodrine
JAMA.
.
No abstract available
Comment in
-
Withdrawing FDA approval of midodrine after marketing.JAMA. 2011 Feb 23;305(8):781-2; author reply 782. doi: 10.1001/jama.2011.161. JAMA. 2011. PMID: 21343575 No abstract available.
Similar articles
-
Withdrawing FDA approval of midodrine after marketing.JAMA. 2011 Feb 23;305(8):781-2; author reply 782. doi: 10.1001/jama.2011.161. JAMA. 2011. PMID: 21343575 No abstract available.
-
FDA takes slow road toward withdrawal of drug approved with fast-track process.JAMA. 2011 Mar 9;305(10):982, 984. doi: 10.1001/jama.2011.269. JAMA. 2011. PMID: 21386071 No abstract available.
-
Does $760 m a year of industry funding affect the FDA's drug approval process?BMJ. 2014 Aug 5;349:g5012. doi: 10.1136/bmj.g5012. BMJ. 2014. PMID: 25096994 No abstract available.
-
Accelerated approval of oncology products: the food and drug administration experience.J Natl Cancer Inst. 2011 Apr 20;103(8):636-44. doi: 10.1093/jnci/djr062. Epub 2011 Mar 21. J Natl Cancer Inst. 2011. PMID: 21422403 Review.
-
Postmarketing surveillance and reporting of adverse drug events.S D J Med. 2004 Jan;57(1):13-4. S D J Med. 2004. PMID: 14964975 Review. No abstract available.
Cited by
-
Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: a multicenter, randomized, placebo controlled trial (the MIDAS trial).BMC Anesthesiol. 2017 Mar 21;17(1):47. doi: 10.1186/s12871-017-0339-x. BMC Anesthesiol. 2017. PMID: 28327122 Free PMC article. Clinical Trial.
-
Midodrine for orthostatic hypotension: a systematic review and meta-analysis of clinical trials.J Gen Intern Med. 2013 Nov;28(11):1496-503. doi: 10.1007/s11606-013-2520-3. Epub 2013 Jun 18. J Gen Intern Med. 2013. PMID: 23775146 Free PMC article.
-
Midodrine for orthostatic hypotension.Aust Prescr. 2021 Feb;44(1):31. doi: 10.18773/austprescr.2020.081. Epub 2020 Dec 17. Aust Prescr. 2021. PMID: 33664549 Free PMC article. Review. No abstract available.
-
The potential risks of expedited approval of drugs for acute bacterial infections.JAMA Intern Med. 2014 Sep;174(9):1436-7. doi: 10.1001/jamainternmed.2014.3055. JAMA Intern Med. 2014. PMID: 25023994 Free PMC article. No abstract available.
-
Conditional Drug Approval as a Path to Market for Oncology Drugs in Canada: Challenges and Recommendations for Assessing Eligibility and Regulatory Responsiveness.Front Med (Lausanne). 2022 Feb 3;8:818647. doi: 10.3389/fmed.2021.818647. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35186979 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
